• About
  • Team
  • Portfolio
  • News
  • Contact
January 31, 2020 in Uncategorized by Christophe Guichard 0 Comments

GeNeuro announces successful €17.5 million private placement

Geneva, Switzerland,  January 31, 2020 – 08:00 CET – GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments focused on stopping causal factors driving the progression of neur ...

Eclosion

Campus Biotech
Innovation Park
Bâtiment F2
Av. Sécheron 15
1201 Geneva
Suisse

Tel: +41 (0)22 544 29 34

    Logo
    Eclosion Ventures © 2021 | Crédits